GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zai Lab Ltd (STU:1ZL) » Definitions » Sale Of Investment

Zai Lab (STU:1ZL) Sale Of Investment : €78.1 Mil (TTM As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Zai Lab Sale Of Investment?

Zai Lab's sale of investment for the three months ended in Mar. 2024 was €15.0 Mil. It means Zai Lab gained €15.0 Mil from selling investments. Zai Lab's sale of investment for the trailing twelve months (TTM) ended in Mar. 2024 was €78.1 Mil.

Compared with last quarter (€14.0 Mil in Dec. 2023 ), Zai Lab gained more money from selling investments in Mar. 2024 (€15.0 Mil).


Zai Lab Sale Of Investment Historical Data

The historical data trend for Zai Lab's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zai Lab Sale Of Investment Chart

Zai Lab Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only 250.19 332.91 658.35 665.78 107.93

Zai Lab Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 46.19 32.35 16.77 14.03 15.00

Zai Lab Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €78.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zai Lab Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Zai Lab's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Zai Lab (STU:1ZL) Business Description

Traded in Other Exchanges
Address
4560 Jinke Road, Jinchuang Plaza, Building 1, 4th Floor, Pudong, Shanghai, CHN, 201210
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatment across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC.

Zai Lab (STU:1ZL) Headlines

No Headlines